Louisiana State Employees Retirement System Invests $2.35 Million in Masimo Corporation $MASI

Louisiana State Employees Retirement System purchased a new position in Masimo Corporation (NASDAQ:MASI) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 13,200 shares of the medical equipment provider’s stock, valued at approximately $2,348,000.

Other hedge funds have also made changes to their positions in the company. Naya Capital Management UK Ltd. acquired a new position in Masimo in the 4th quarter worth approximately $202,984,000. AQR Capital Management LLC raised its stake in Masimo by 3,416.5% during the 4th quarter. AQR Capital Management LLC now owns 1,091,326 shares of the medical equipment provider’s stock valued at $141,938,000 after purchasing an additional 1,060,292 shares during the period. Viking Global Investors LP acquired a new stake in Masimo during the 2nd quarter valued at $129,096,000. Squarepoint Ops LLC lifted its holdings in shares of Masimo by 738.8% in the third quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider’s stock valued at $91,619,000 after purchasing an additional 546,905 shares in the last quarter. Finally, SG Americas Securities LLC lifted its holdings in shares of Masimo by 3,082.3% in the first quarter. SG Americas Securities LLC now owns 522,824 shares of the medical equipment provider’s stock valued at $92,995,000 after purchasing an additional 506,395 shares in the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on MASI. Raymond James Financial lowered Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Weiss Ratings raised Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Finally, Wells Fargo & Company upgraded Masimo to a “hold” rating in a report on Wednesday, March 18th. Nine analysts have rated the stock with a Hold rating, According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $180.40.

Masimo Stock Performance

Shares of NASDAQ:MASI opened at $179.95 on Tuesday. The firm has a fifty day moving average of $179.03 and a two-hundred day moving average of $163.58. The firm has a market capitalization of $9.42 billion, a P/E ratio of -17.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.11. Masimo Corporation has a 12-month low of $125.94 and a 12-month high of $179.99. The company has a quick ratio of 1.45, a current ratio of 2.68 and a debt-to-equity ratio of 0.56.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.